MeSH tree: C15
A two-headed molecule designed by Stanford Medicine researchers hijacks one of the most common protein drivers of B-cell lymphoma, flipping it from its role as a promoter of cell growth into an arbiter of cell death. In mice, ...
Aug 20, 2026
0
37
Adults who have survived Hodgkin lymphoma (HL) for at least five years face significantly elevated long-term health risks, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
Aug 19, 2026
0
3
Giving intravenous iron to patients with anemia before heart surgery reduces the need for a red blood cell transfusion, finds a clinical trial published by The BMJ today. Intravenous iron also saved approximately 44 units ...
Aug 19, 2026
0
10
Biologic medicines have transformed the treatment of cancer, autoimmune diseases, migraine, inflammatory disorders and many other conditions. Yet their growing use among women of reproductive age constitutes a major clinical ...
Aug 14, 2026
0
6
The devastating recent deaths of three toddlers in Queensland, linked to low iron levels, have understandably left many parents wondering whether their own child is getting enough iron. The good news is that life-threatening ...
Aug 14, 2026
0
7
Researchers at National Jewish Health and partner institutions have discovered specific changes in immune cells in the lungs of people with sarcoidosis. Their findings help explain how this inflammatory disease develops and ...
Aug 11, 2026
0
5
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients ...
Aug 10, 2026
0
6
For people with lymphoma, getting the right diagnosis can be a race against time.
Aug 10, 2026
0
3
Flinders University researchers have evaluated two next-generation reasoning large language models (LLMs)—o3-mini and DeepSeek-R1—and found that when asked to describe fictional patients with common medical conditions, the ...
Aug 7, 2026
0
8
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells. Researchers at Baylor College ...
Aug 7, 2026
0
10
